Insider Trading History of O Leary Robert

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by O Leary Robert since 2006. The trader's CIK number is 1201946. At the time of the last reporting, O Leary Robert was the Director of Valeant Pharmaceuticals International. (stock ticker symbol VRX). Also see all insider trading activities at Valeant Pharmaceuticals International.

Note that in the past O LEARY ROBERT also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Valeant Pharmaceuticals International (VRX) by O Leary Robert

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 VRX 0 $0 0 $0 39,800 $399,990

Yearly summary of insider trading at Viasys Healthcare Inc (VAS) by O Leary Robert

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 VAS 0 $0 43,413 $1,270,124 36,514 $600,785


Insider trading activities at 2 companies by O Leary Robert:

1. Valeant Pharmaceuticals International (VRX)

2. Viasys Healthcare Inc (VAS)

Table 1. Insider trading of Valeant Pharmaceuticals International (VRX) by O Leary Robert

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-08-02 VRX Option Ex 39,800 10.05 399,990

Table 2. Insider trading of Viasys Healthcare Inc (VAS) by O Leary Robert

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-03-02 VAS Sale 11,700 29.16 341,125
2006-03-02 VAS Option Ex 11,700 14.23 166,491
2006-03-02 VAS Sale 24,814 29.29 726,752
2006-03-02 VAS Option Ex 24,814 17.50 434,294
2006-03-02 VAS Sale 5,000 29.31 146,550
2006-03-01 VAS Sale 1,899 29.33 55,697

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by O Leary Robert (Director of Valeant Pharmaceuticals International at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.